Stay updated with breaking news from Arch Intern Med. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The study should include 12 patients, and its launch is expected in the third quarter of 2023NANTES, France--(BUSINESS WIRE)--Regulatory News:Pherecydes Pharma (FR0011651694 - ALPHE), a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, today ann...
In the final instalment of the Cholesterol Con series, Noakes concludes the account of the greatest scam in the history of modern medicine.
Perhaps the most shocking article in the Cholesterol Con series, Part Twelve details the depths of institutional collusion and corruption.
9.3% of Americans and 6.5% of Canadians suffer from diabetes. There is a lot of agreement about the medical ...
Noakes continues the story of Keys' cholesterol con starting with the reporting of the first findings in the Framingham Heart Study in 1957.